<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02147093</url>
  </required_header>
  <id_info>
    <org_study_id>CR-5175</org_study_id>
    <nct_id>NCT02147093</nct_id>
  </id_info>
  <brief_title>CLARITI (TM) 1-Day Multifocal Contact Lenses Performance and Acceptance Evaluation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A comparative evaluation of a newly marketed multifocal contact lens with a single vision
      contact lens when used with near vision spectacles. The evaluation was to quantify the
      difference between the two test corrections.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2014</start_date>
  <completion_date type="Actual">August 1, 2014</completion_date>
  <primary_completion_date type="Actual">August 1, 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance LogMAR Visual Acuity</measure>
    <time_frame>7 days post wear</time_frame>
    <description>Distance time controlled LogMAR (Logarithm of the Minimum Angle of Resolution) Visual Acuity was carried out binocularly, at 4m (meter) under 250 cd/m^2 and 2.5 cd/m^2 (candela per square meter) luminance. The test was presented under the two conditions; High luminance (250 cd/m^2) High Contrast (90%) &amp; Low Contrast (10%) and Low Luminance (2.5 cd/m^2) High Contrast (90%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Near LogMAR Visual Acuity</measure>
    <time_frame>7 days post wear</time_frame>
    <description>Near time controlled LogMAR Visual Acuity was carried out binocularly, at 4cm under 250 cd/m^2 and 50 cd/m^2 luminance. The test was presented on under the two conditions; High Luminance (250cd/m^2) High Contrast (90%) &amp; Low Contrast (10%) and Low Luminance (50cd/m^2) High Contrast (90%)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Presbyopia Correction</condition>
  <arm_group>
    <arm_group_label>Control (sphere) /Test (multi-focal)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects were first fitted with Control lens (sphere) and a pair of reading glasses for one week. Subjects were then fitted with the Test lens (multi-focal) for one week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test (sphere) /Control (multi-focal)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects were first fitted with the Test lens (multi-focal) for one week. Subjects were then fitted with Control lens (sphere) and a pair of reading glasses for one week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Test (multi-focal)</intervention_name>
    <description>contact lens was to be worn a daily wear.</description>
    <arm_group_label>Control (sphere) /Test (multi-focal)</arm_group_label>
    <arm_group_label>Test (sphere) /Control (multi-focal)</arm_group_label>
    <other_name>Clariti 1 Day</other_name>
    <other_name>filcon II 3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control (Sphere)</intervention_name>
    <description>contact lens was to be worn a daily wear with spectacles</description>
    <arm_group_label>Control (sphere) /Test (multi-focal)</arm_group_label>
    <arm_group_label>Test (sphere) /Control (multi-focal)</arm_group_label>
    <other_name>filcon II 3</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 45 years or more

          2. Spectacle or soft contact lens wearer

          3. Refraction: best sphere (corrected for back vertex distance) -6.00 Diopters (D) to
             +4.00 D; Astigmatism - 0.00 D to -0.75 D; Near addition for 40 cm; Medium Add: +1.50 D
             to +2.00 D; High Add: +2.25 D to +2.50 D

          4. Best spectacle corrected visual acuity of 6/9 or better in each eye

          5. Willingness to adhere to the instructions set forth in the clinical protocol

          6. Signature of the subject Informed Consent form after review of Information to
             Participant document.

        Exclusion Criteria:

          1. Systemic or ocular allergies which might interfere with contact lens wear

          2. Systemic disease which might interfere with contact lens wear

          3. Ocular disease which might interfere with contact lens wear (e.g. hypothesia,
             insufficient lacrimal secretion)

          4. Use of medication which might interfere with contact lens wear

          5. Active ocular infection

          6. Use of ocular medication

          7. Significant ocular anomaly

          8. Presence of two or more corneal scars in either eye

          9. Monovision contact lens wearers

         10. Pregnancy or lactation

         11. Any medical condition that might be prejudicial to the study

         12. Participants non-able to give consent or from a vulnerable group

         13. Infectious disease (for example, hepatitis, tuberculosis, etc.) or a contagious
             immunosuppressive disease (such as HIV, AIDS, etc.)

         14. Employees or family member of the investigational clinic (e.g. investigator,
             coordinator, technician)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>London</city>
        <zip>SW1E6AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2014</study_first_submitted>
  <study_first_submitted_qc>May 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2014</study_first_posted>
  <results_first_submitted>September 22, 2015</results_first_submitted>
  <results_first_submitted_qc>June 10, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 20, 2016</results_first_posted>
  <last_update_submitted>June 14, 2017</last_update_submitted>
  <last_update_submitted_qc>June 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 41 subjects were enrolled in this study. Of the enrolled subjects 1 did not meet the eligibility criteria and 40 subjects were dispensed a study lens. Of the dispensed subjects, 3 were discontinued and 37 subjects completed the study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Control (Filcon II 3- Sphere) /Test (Filcon II 3-multi-focal)</title>
          <description>Subjects were first fitted with the Control lens (filcon II 3- sphere) and a pair of reading glasses for one week. Subjects were then fitted with the Test lens (filcon II 3-multi-focal) for one week.</description>
        </group>
        <group group_id="P2">
          <title>Test (Filcon II 3-multi-focal) /Control (Filcon II 3- Sphere)</title>
          <description>Subjects were first fitted with the Test lens (filcon II 3-multi-focal) for one week. Subjects were then fitted with Control lens (filcon II 3- sphere) and a pair of reading glasses for one week.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Period 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All subjects that were randomized to one of two lens wear serquences.</population>
      <group_list>
        <group group_id="B1">
          <title>Control (Filcon II 3-sphere) /Test (Filcon II 3-multi-focal)</title>
          <description>All subjects that were randomized to sequence and were dispensed a study lens.</description>
        </group>
        <group group_id="B2">
          <title>Test (Filcon II 3-multi-focal) / Control (Filcon II 3-spher)</title>
          <description>All subjects that were randomized to sequence and were dispensed a study lens.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.20" spread="7.682"/>
                    <measurement group_id="B2" value="58.00" spread="9.067"/>
                    <measurement group_id="B3" value="56.78" spread="8.490"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Distance LogMAR Visual Acuity</title>
        <description>Distance time controlled LogMAR (Logarithm of the Minimum Angle of Resolution) Visual Acuity was carried out binocularly, at 4m (meter) under 250 cd/m^2 and 2.5 cd/m^2 (candela per square meter) luminance. The test was presented under the two conditions; High luminance (250 cd/m^2) High Contrast (90%) &amp; Low Contrast (10%) and Low Luminance (2.5 cd/m^2) High Contrast (90%)</description>
        <time_frame>7 days post wear</time_frame>
        <population>All subjects that completed all study visits without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Control (Filcon II 3-sphere)</title>
            <description>Subjects that were dispensed the Control lens (filcon II 3-sphere) in either the first or second period of the study.</description>
          </group>
          <group group_id="O2">
            <title>Test (Filcon II 3-multi-focal)</title>
            <description>Subjects that were dispensed the Test lens (filcon II 3-multi-focal) in either the first or second period of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Distance LogMAR Visual Acuity</title>
          <description>Distance time controlled LogMAR (Logarithm of the Minimum Angle of Resolution) Visual Acuity was carried out binocularly, at 4m (meter) under 250 cd/m^2 and 2.5 cd/m^2 (candela per square meter) luminance. The test was presented under the two conditions; High luminance (250 cd/m^2) High Contrast (90%) &amp; Low Contrast (10%) and Low Luminance (2.5 cd/m^2) High Contrast (90%)</description>
          <population>All subjects that completed all study visits without a major protocol deviation.</population>
          <units>LogMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>High Contrast-Distance-Standard High Luminance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.466" spread="0.9995"/>
                    <measurement group_id="O2" value="-0.972" spread="1.0104"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Low Contrast-Distance-Standard High Luminance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.842" spread="1.6850"/>
                    <measurement group_id="O2" value="-3.768" spread="1.8023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>High Contrast-Distance-Standard Low Luminance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.834" spread="1.0042"/>
                    <measurement group_id="O2" value="-3.700" spread="0.8939"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Near LogMAR Visual Acuity</title>
        <description>Near time controlled LogMAR Visual Acuity was carried out binocularly, at 4cm under 250 cd/m^2 and 50 cd/m^2 luminance. The test was presented on under the two conditions; High Luminance (250cd/m^2) High Contrast (90%) &amp; Low Contrast (10%) and Low Luminance (50cd/m^2) High Contrast (90%)</description>
        <time_frame>7 days post wear</time_frame>
        <population>All subjects that completed all study visits without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Control (Filcon II 3-sphere)</title>
            <description>Subjects that were dispensed the Control lens (filcon II 3-sphere) in either the first or second period of the study.</description>
          </group>
          <group group_id="O2">
            <title>Test (Filcon II 3-multi-focal)</title>
            <description>Subjects that were dispensed the Test lens (filcon II 3-multi-focal) in either the first or second period of the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Near LogMAR Visual Acuity</title>
          <description>Near time controlled LogMAR Visual Acuity was carried out binocularly, at 4cm under 250 cd/m^2 and 50 cd/m^2 luminance. The test was presented on under the two conditions; High Luminance (250cd/m^2) High Contrast (90%) &amp; Low Contrast (10%) and Low Luminance (50cd/m^2) High Contrast (90%)</description>
          <population>All subjects that completed all study visits without a major protocol deviation.</population>
          <units>LogMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>High Contrast-Near-Standard High Luminance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.455" spread="0.6309"/>
                    <measurement group_id="O2" value="-2.545" spread="1.1240"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Low Contrast-Near-Standard High Luminance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.151" spread="1.0221"/>
                    <measurement group_id="O2" value="-3.820" spread="1.4124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>High Contrast-Near-Standard Low Luminance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.878" spread="1.0546"/>
                    <measurement group_id="O2" value="-3.441" spread="1.3941"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Throughout duration of the study(approximately 4 months).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Control (Filcon II 3-sphere)</title>
          <description>Subjects that were dispensed the Control lens (filcon II 3-sphere) in either the first or second period of the study.</description>
        </group>
        <group group_id="E2">
          <title>Test (Filcon II 3-multi-focal)</title>
          <description>Subjects that were dispensed the Test lens (filcon II 3-multi-focal) in either the first or second period of the study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tom Karkkainen, OD, MS, FAAO</name_or_title>
      <organization>Johnson &amp; Johnson Vision Care INC.</organization>
      <phone>904-443-3500 ext 3402</phone>
      <email>TKarkkai@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

